4 ms·
The winner in the cancer diagnostic space is going to be who can sequence the most cancers vs germlines. At least where cell free DNA is concerned.
by sjg007 10y ago
The winner in the cancer diagnostic space is going to be who can sequence the most cancers vs germlines. At least where cell free DNA is concerned.
- rgejman 10y agoWe already know the major drivers in most tumor types. These are the early mutations that you are going to look for in cell free DNA. Additional cancer-normal pairs are not going to elucidate many new driver mutations. Only careful prospective trials will identify sensitive and specific diagnostics. Those will be the winners (and they will probably be academics).